Back to search

Article

Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cell therapy

2022-10-31

Abstract excerpt

<h4>ABSTRACT</h4> Adoptive cell transfer (ACT) therapy with IL-17 producing human T cells elicits potent antitumor activity in preclinical models. However, further refinement of this novel approach is needed to position it for clinical application. While activation signal strength differentially regulates IL-17 production by human CD4 + T cells, the degree to which TCR and co-stimulation signal strength impacts...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5f41e6d4-ea78-5145-95a0-78e9d37ab279
DOI
10.1101/2022.10.28.514057
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Augmenting TCR signal strength and ICOS costimulation results in metabolically fit and therapeutically potent human CAR Th17 cell therapyDOI 10.1101/2022.10.28.514057
Select a neighboring publication to make it the new centre.